Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.

CRISPR Therapeutics (NASDAQ: CRSP), a mid-cap biotech company, achieved a major milestone when it earned approval for the ...

In recent times, this has proven to be GLP-1 drugs, treatments that have helped patients worldwide safely and rather quickly ...

Most asset managers try to track the market. Through ARK Investment, Cathie Wood is trying to get ahead of the market’s best ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $52.06, marking a +2.1% move from the previous day. This change outpaced the S&P 500's 0.49% loss on the day. Elsewhere, the Dow ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $55.72, moving -1.83% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.26%. On ...